Michael G. Kharas

9.2k total citations · 2 hit papers
77 papers, 5.6k citations indexed

About

Michael G. Kharas is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Michael G. Kharas has authored 77 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 29 papers in Hematology and 15 papers in Oncology. Recurrent topics in Michael G. Kharas's work include RNA Research and Splicing (20 papers), RNA modifications and cancer (16 papers) and Acute Myeloid Leukemia Research (15 papers). Michael G. Kharas is often cited by papers focused on RNA Research and Splicing (20 papers), RNA modifications and cancer (16 papers) and Acute Myeloid Leukemia Research (15 papers). Michael G. Kharas collaborates with scholars based in United States, Germany and Canada. Michael G. Kharas's co-authors include Yuanming Cheng, Samie R. Jaffrey, Ly Vu, Rachel Okabe, D. Gary Gilliland, Gerard Minuesa, Diu Nguyen, George Q. Daley, Brian F. Pickering and Christopher J. Lengner and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael G. Kharas

74 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

2017 932 citations Ly Vu, Brian F. Pickering et al. profile →
The Lin28/let-7 Axis Regulates Glucose Metabolism

2011 724 citations William S. Einhorn, Michael G. Kharas et al. profile →

Peers

Countries citing papers authored by Michael G. Kharas

Since Specialization

Citations

This map shows the geographic impact of Michael G. Kharas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Kharas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Kharas more than expected).

Fields of papers citing papers by Michael G. Kharas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Kharas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Kharas. The network helps show where Michael G. Kharas may publish in the future.

Co-authorship network of co-authors of Michael G. Kharas

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Kharas. A scholar is included among the top collaborators of Michael G. Kharas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Kharas. Michael G. Kharas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N6-Methyladenosine: an RNA modification as a central regulator of cancer 2025 ·Nature reviews. Cancer ·Hanzhi Luo, Michael G. Kharas, Samie R. Jaffrey	0
2	Dotting Out AML by Targeting Fibrillarin 2024 ·Cancer Research ·Hanzhi Luo, Michael G. Kharas	4
3	A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML 2023 ·Blood ·Tao Dao, Guangyan Xiong, (unknown), (unknown), Tatyana Korontsvit, J Xiang, Ziyou Cui, Aaron Y. Chang, Casey A. Jarvis, (unknown), Hanzhi Luo, (unknown), Anthony F. Daniyan, Sarah Yoo, Sumiko Takao, Michael G. Kharas, Alex Kentsis, Liu C, David A. Scheinberg	18
4	Design and Development of IKZF2 and CK1α Dual Degraders 2023 ·Journal of Medicinal Chemistry ·David K. Miyamoto, (unknown), Sun‐Mi Park, (unknown), Michael G. Kharas, Christina M. Woo	13
5	Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle 2023 ·Endocrinology ·(unknown), (unknown), Alicja Urbaniak, (unknown), (unknown), (unknown), Linda Hardy, Anessa Haney, (unknown), Tiffany K. Miles, Allen Gies, Stephanie D. Byrum, Ania Wilczynska, Ulrich Boehm, Michael G. Kharas, Christopher J. Lengner, Melanie C MacNicol, Gwen V. Childs, Angus M. MacNicol, Angela K. Odle	5
6	Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia 2021 ·eLife ·Sumiko Takao, Lauren Forbes, (unknown), Shuyuan Cheng, Jose Mario Bello Pineda, Yusuke Tarumoto, Paolo Cifani, Gerard Minuesa, Celine Chen, Michael G. Kharas, Robert K. Bradley, Christopher R. Vakoc, Richard P. Koche, Alex Kentsis	34
7	Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target 2021 ·Leukemia ·Florencia Palacios, Xiao‐Jie Yan, Gerardo Ferrer, Shih‐Shih Chen, Stefano Vergani, Xuejing Yang, Jeffrey R. Gardner, Jacqueline C. Barrientos, (unknown), Richard Burack, Jonathan E. Kolitz, Steven L. Allen, Michael G. Kharas, Omar Abdel‐Wahab, R. Kanti, Nicholas Chiorazzi	18
8	RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction 2020 ·Nature Communications ·Mauro Montalbano, Salomé McAllen, Nicha Puangmalai, Urmi Sengupta, Nemil Bhatt, (unknown), Michael G. Kharas, Rakez Kayed	67
9	High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells 2020 ·Cell Metabolism ·Sangmoo Jeong, Angela Maria Savino, Rachel Chirayil, Ersilia Barin, Yuanming Cheng, Sun‐Mi Park, Alexandra Schurer, Edouard Mullarky, Lewis C. Cantley, Michael G. Kharas, Kayvan R. Keshari	51
10	High-speed automatic characterization of rare events in flow cytometric data 2020 ·PLoS ONE ·Yuan Qi, (unknown), David R. Sinclair, Shangqin Guo, Meritxell Alberich-Jordà, Jun Lü, Daniel G. Tenen, Michael G. Kharas, Saumyadipta Pyne	2
11	HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells 2020 ·Nature Communications ·Diu Nguyen, Yuheng Lu, (unknown), Xuejing Yang, Sun‐Mi Park, Zi-Ning Choo, Christopher R. Chin, (unknown), Alexandra Schurer, Ersilia Barin, Angela Maria Savino, Saroj Gourkanti, Payal T. Patel, Ly Vu, Christina S. Leslie, Michael G. Kharas	36
12	γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs 2020 ·Journal of Nuclear Medicine ·Sanggyu Lee, Teja Kalidindi, (unknown), (unknown), Blesida Punzalan, (unknown), Casey J. Lee, Hebert Alberto Vargas, (unknown), Lisa Bodei, Michael G. Kharas, Vijay K. Singh, Nagavarakishore Pillarsetty, Steven M. Larson	6
13	m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment 2019 ·Cell Reports ·Yuanming Cheng, Hanzhi Luo, Franco Izzo, Brian F. Pickering, Diu Nguyen, Robert M. Myers, Alexandra Schurer, Saroj Gourkanti, Jens C. Brüning, Ly Vu, Samie R. Jaffrey, Dan A. Landau, Michael G. Kharas	126
14	Stem Cells, Cancer, and MUSASHI in Blood and Guts 2017 ·Trends in cancer ·Michael G. Kharas, Christopher J. Lengner	41
15	Msi RNA-binding proteins control reserve intestinal stem cell quiescence 2016 ·The Journal of Cell Biology ·Maryam Yousefi, Ning Li, Angela Nakauka‐Ddamba, Shan Wang, (unknown), (unknown), Zhengquan Yu, Shane T. Jensen, Michael G. Kharas, Christopher J. Lengner	49
16	Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs 2014 ·The Journal of Experimental Medicine ·Sun‐Mi Park, Raquel P. Deering, Yuheng Lu, Patrick Tivnan, Steve Lianoglou, Fátima Al‐Shahrour, Benjamin L. Ebert, Nir Hacohen, Christina S. Leslie, George Q. Daley, Christopher J. Lengner, Michael G. Kharas	110
17	Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein 2014 ·Clinical Cancer Research ·Nicholas Veomett, Tao Dao, Hong Liu, Jingyi Xiang, Dmitry Pankov, Leonid Dubrovsky, (unknown), Sun‐Mi Park, Tatyana Korontsvit, Victoria Zakhaleva, Emily Casey, Michael Curcio, Michael G. Kharas, Richard J. O’Reilly, Liu C, David A. Scheinberg	41
18	The Src homology-2 protein Shb modulates focal adhesion kinase signaling in a BCR-ABL myeloproliferative disorder causing accelerated progression of disease 2014 ·Journal of Hematology & Oncology ·Karin Gustafsson, (unknown), (unknown), Michael G. Kharas, Michael Welsh	10
19	Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia 2010 ·DSpace@MIT (Massachusetts Institute of Technology) ·Michael G. Kharas, Christopher J. Lengner, Fátima Al‐Shahrour, Lars Bullinger, Brian Ball, Samir Zaidi, Kelly Morgan, Winnie F. Tam, Mahnaz Paktinat, Rachel Okabe, Maricel Gozo, William S. Einhorn, Steven Lane, Claudia Scholl, Stefan Fröhling, Mark D. Fleming, Benjamin L. Ebert, D. Gary Gilliland, Rudolf Jaenisch, George Q. Daley	2
20	Measuring Phosphorylated Akt and Other Phosphoinositide 3-kinase-Regulated Phosphoproteins in Primary Lymphocytes 2007 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Amber C. Donahue, Michael G. Kharas, (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact